Aldose reductase: A window to the treatment of diabetic complications?

Progress in Retinal and Eye Research

Volumn 17, Issue 3, 1998, Pages 313-383

  Crabbe, M James C ^a   Goode, Derek ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; ASCORBIC ACID; ENZYME INHIBITOR; EPALRESTAT; MONOSACCHARIDE; MYOINOSITOL 1 PHOSPHATE SYNTHASE; OXIDOREDUCTASE; PONALRESTAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SORBINIL; TOLRESTAT; XYLITOL; ZOPOLRESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; CATARACT; CLINICAL TRIAL; CRYSTAL STRUCTURE; DIABETES MELLITUS; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE EXPRESSION; GENE INDUCTION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDEHYDE REDUCTASE; ANIMALS; CATARACT; CATTLE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME INHIBITORS; HUMANS; LENS, CRYSTALLINE; RATS; RETINA; SUGAR ALCOHOLS;

EID: 0031875592     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(97)00013-X     Document Type: Article

References (281)

1. Bakillah, A., Grigorovaborsos, A. M., Guillot, R., Urios, P. and Sternberg, M. (1996) Effect of an aldose reductase inhibitor on type-IV collagen production by human endothelial-cells cultured in high glucose. Diabetologia 39, 641-648.
2. Bardsley, W. G., Crabbe, M. J. C. and Scott, I. V. (1974) The amine oxidases of human placenta and pregnancy plasma. Biochem. J. 139, 183-189.
3. Bartels, D., Engelhardt, K., Roncarati, R., Schneider, K., Rotter, M. and Salamini, F. (1991) An ABA and GA modulated gene expressed in the barley embryo encodes an aldose reductase related protein. EMBO J. 10, 1037-1043.
4. Basak Halder, A. and Crabbe, M. J. C. (1985) Chemical modification studies on purified bovine lens aldose reductase. Ophthal. Res. 17, 185-188.
5. Basnet, P., Kadota, S., Hase, K. and Namba, T. (1995) 5 new C-methyl flavonoids, the potent aldose reductase inhibitors from Matteuccia orientalis Trev. Chem. Pharmaceut. Bull. 43, 1558-1564.
6. Baynes, J. W. (1996) The role of oxidation in the Maillard reaction in vivo. In: The Maillard Reaction (R. Ikan, ed.) pp. 55-88.
7. Belai, A., Calcutt, N. A., Carrington, A. L., Diemel, L. T., Tomlinson, D. R. and Burnstock, G. (1996) Enteric neuropeptides in streptozotocin-diabetic rats - effects of insulin and aldose reductase inhibition. J. Autonomic Nervous System 58, 163-169.
8. Bertimattera, L., Day, N., Peterson, R. G. and Eichberg, J. (1996) An aldose reductase inhibitor but not myoinositol blocks enhanced polyphosphoinositide turnover in peripheral-nerve from diabetic rats. Metabolism Clin. Exp. 45, 320-327.
9. Bhatnagar, A., Liu, S. Q., Ueno, N., Chakrabarti, B. and Srivastava, S. K. (1994) Human placental aldose reductase - role of CYS-298 in substrate and inhibitor binding. Biochim. Biophys. Acta 1205, 207-214.
10. Bielski, B. H. J. and Chan, P. C. (1976) Re-evaluation of the kinetics of lactate dehydrogenase-catalysed chain oxidation of nicotinamide adenine dinucleotide by superoxide radicals in the presence of ethylenediamine-tetraacetate. J. Biol. Chem. 251, 3841-3844.
11. Bohren, K. M., Grimshaw, C. E., Lai, C. J., Harrison, D. H., Ringe, D., Petsko, G. A. and Gabbay, K. H. (1994) Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase-enzyme-kinetics and crystal-structure of the Y48H mutant enzyme. Biochemistry 33, 2021-2032.
12. Brownlee, M., Vlassara, H. and Cerami, A. (1987) The pathogenic role of non-enzymatic glycosylation in diabetic complications. In: Diabetic complications (M. J. C. Crabbe, ed.) pp. 94-139. Churchill Livingstone, Edinburgh.
13. Brownlee, M., Vlassara, H. and Kooney T. et al. 1986 Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232, 1629-1932.
14. Burchell, B. and Weatherill, P. (1981) UDP glucuronyl transferase. Methods Enzymol. 77, 169-174.
15. Caird, F. I., Hutchinson, M. and Pirie, A. (1964) Cataract and diabetes. Br. Med. J. 2, 665.
16. Calcutt, N. A., Li, L., Yaksh, T. L. and Malmberg, A. B. (1995) Different effects of 2 aldose reductase inhibitors on nociception and prostaglandin-E. Eur. J. Pharmacol. 285, 189-197.
17. Calcutt, N. A., McMurray, H. F., Moorhouse, D. F., Bache, M., Parthasarathy, S., Powell, H. C. and Mizisin, A. P. (1994a) Inhibition of macrophage chemotaxis and peripheral-nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor tolrestat. Experimental Neurology 128, 226-232.
18. Calcutt, N. A., Mizisin, A. P. and Kalichman, M. W. (1994b) Aldose reductase inhibition, doppler flux and conduction in diabetic rat nerve. Eur. J. Pharmacol. 251, 27-33.
19. Cameron, N. E., Cotter, M. A., Dines, K. C. and Hohman, T. C. (1996) Reversal of defective peripheral-nerve conduction-velocity, nutritive endoneurial blood-flow, and oxygenation by a novel aldose reductase inhibitor, way-121,509, in streptozotocin-induced diabetic rats. J. Diabetes and its complications 10, 43-53.
20. Cameron, N. E., Cotter, M. A., Dines, K. C., Maxfield, E. K., Carey, F. and Mirrlees, D. J. (1994) Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats - dose-response considerations and independence from a myoinositol mechanism. Diabetologia 37, 651-663.
21. Cappiello, M., Vilardo, P. G., Cecconi, I., Leverenz, V., Giblin, F. J., Delcorso, A. and Mura, U. (1995) Occurrence of glutathione-modified aldose reductase in oxidatively stressed bovine lens. Biochem. Biophys. Res. Commun. 207, 775-782.
22. Carper, D. A., Hohman, T. C. and Old, S. E. (1995) Residues affecting the catalusis and inhibition of rat lens aldose reductase. Biochim. Biophys. Acta 1246, 67-73.
23. Carper, D., Nishimura, C. and Graham, C. et al. (1987) The primary structure of rat lens aldose reductase. FEBS Lett. 220, 209.
24. Carper, D., Nishimura, C. and Graham, C. et al. (1988) The primary structure of rat lens aldose reductase. Investigative Ophthalmology 29(suppl), 319.
25. Cerami, A. and Crabbe, M. J. C. (1986) Recent advances in cataract research. Trends Pharm. Sci. 7, 271-271.
26. Chandra, A., Srivastava, S., Petrash, J. M., Bhatnagar, A. and Srivastava, S. K. (1997) Modification of aldose reductase by S-nitrosoglutathione. Biochemistry 36, 15801-15809.
27. Charalampous, F. C. (1962) Inositol oxygen oxidoreductase. Methods Enzymol. 5, 329-331.
28. Chitpinityol, S., Goode, D. and Crabbe, M. J. C. (1998) Interactions between alpha crystallin and recombinant prochymosins and chymosin. Molecular Vision 4, 1-11.
29. Cohenmelamed, E., Nyska, A., Pollack, A. and Madar, Z. (1995) Aldose reductase (EC1.1.1.21). Activity and reduced-glutathione content in lenses of diabetic sand rats (psammomys-obesus) fed with acarbose. Br. J. Nutr. 74, 607-615.
30. Cook, P. N., Ward, W. H. J., Petrash, J. M., Mirrlees, D. J., Sennitt, C. M., Carey, F., Preston, J., Brittain, D. R., Tuffin, D. P. and Howe, R. (1995) Kinetic characteristics of Zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductase. Biochem. Pharmacol. 49, 1043-1049.
31. Cotlier, E. and Sharma, Y. R. (1981) Asprin and senile cataracts in rheumatoid arthritis. Lancet I, 338-339.
32. Coudert, P., Albuisson, E., Boire, J. Y., Duroux, E., Bastide, P. and Couquelet, J. (1994) Synthesis of pyridazine acetic-acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties. Eur. J. Med. Chem. 29, 471-477.
33. 13C nuclear magnetic resonance spectroscopy of glucose metabolism in the human lens. Investigative Ophthalmology 26(suppl), 314.
34. Crabbe, M. J. C. (1987a) Diabetic complications: scientific and clinical aspects, pp. 1-23. Churchill Livingstone, Edinburgh.
35. Crabbe, M. J. C. (1987b) Diabetic Complications: Scientific and Clinical Aspects, pp. 140-166. Churchill Livingstone, Edinburgh.
36. Crabbe, M. J. C. (1991) Aldose reductase inhibitors and cataract. Int. Ophthalmol. 15, 25-36.
37. Crabbe, M. J. C., Appleyard, J. and Rees Lay, C. (1994) Desk Top Molecular Modeller; Molecular Modelling Software and Manual for the IBM PC. Version 3.0. Oxford Electronic Publishing, Oxford University Press, Oxford, UK.
38. Crabbe, M. J. C. and Bardsley, W. G. (1974) Monoamine oxidase inhibitors and other drugs as inhibitors of diamine oxidase from human placenta and pig kidney. Biochem. Pharmacol. 23, 2983-2990.
39. Crabbe, M. J. C., Bron, A. J., Peckar, C. O., Petchey, M., Ting, H.-H. and Howard-Williams, J. (1983) NADPH-oxidising activity in lens and erythrocytes in diabetic and non-diabetic patients with cataract. Br. J. Ophthalmol. 67, 696-699.
40. Crabbe, M. J. C., Childs, R. E. and Bardsley, W. G. (1975) Time-dependent inhibition of diamine oxidase by carbonyl group reagents and urea. Eur. J. Biochem. 60, 325-333.
41. Crabbe, M. J. C., Halder, A. B., Peckar, C. O. and Cheng H. (1980) Erythrocyte glyceraldehyde reductase levels in diabetics with retinopathy and cataract. Lancet 1268-1270.
42. Crabbe, M. J. C. and Hoe, S. T. (1992) Aldehyde dehydrogenase, aldose reductase, and free radical scavengers in cataract. Enzyme 45, 188-193.
43. Crabbe, M. J. C., Petchey, M., Burgess, S. E. P. and Cheng, H. (1985) The penetration of sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction. Exp. Eye Res. 40, 95-99.
44. Crabbe, M. J. C., Petchey, M. and Wolff, S. P. (1986a) Monosaccharide-induced NADPH oxidation (AR2 activity) and the uptake of sorbinil and myo-inositol in incubated rat lenses. Lens Res. 3, 69-91.
45. Crabbe, M. J. C. and Wolff, S. P. (1987) Rat lens AR2 and polyol production. Biochem. J. 247, 493-496.
46. Crabbe, M. J. C., Wolff, S. P. and Lloyd P. (1986) Monosaccharide autoxidation, cataract and AR2 activity, In: The Lens: Transparency and Cataract (G. Duncan, ed.) pp. 119-0126. Eurage, Amsterdam.
47. Creighton, M. O. and Trevithick, J. R. (1979) Cortical cataract formation prevented by vitamin E and glutathione. Exp. Eye Res. 29, 689-693.
48. Cunningham, J. J., Mearkle, P. L. and Brown, R. G. (1994) Vitamin-C-an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes-mellitus. J. Am. Coll. Nutr. 13, 344-350.
49. Dahlin, L. B., Archer, D. R. and McLean, W. G. (1987) Treatment with an AR2 inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat. Diabetologia 30, 414-418.
50. Das, D., Song, H. P. and Srivastava, S. K. (1987) Conversion of glucose to sorbitol by AR2. Investigate Ophthalmology 28(suppl), 281.
51. Dasettimo, A., Primofiore, G., Dasettimo, F., Simorini, F., Lamotta, C., Martinelli, A. and Boldrini, E. (1996a) Synthesis of pyrrolo [3,4-C] pyridine derivatives possessing an acid group and their in-vitro and in-vivo evaluation as aldose reductase inhibitors. Eur. J. Med. Chem. 31, 49-58.
52. Dasettimo, A., Primofiore, G., Lamotta, C., Dasettimo, F., Simorini, F., Boldrini, E. and Bianchini, P. (1996b) Acid-derivatives of benzisothiazole-1, 1-dioxide as inhibitors of rat lens aldose reductase. Farmaco 51, 261-267.
53. Delcorso, A., DalMonte, M., Vilardo, P. G., Cecconi, I., Moschini, R., Banditelli, S., Cappiello, M., Tsai, L. and Mura, V. (1998) Site specific inactivation of aldose reductase by 4-hydroxy nonenal. Arch. Biochem. Biophys. 350, 245-248.
54. Dent, M. T., Veves, A., Tebbs, S. E., Gonzalez, A. M., Malik, R. A., Boulton, A. J. M., Ward, J. D. and Wilson, R. M. (1991) Neutrophil aldose reductase activity as a potential marker for neuropathy and cataract in diabetes. Diabetic Med. 8, 911-916.
55. Deruiter, J., Jacyno, J. M., Cutler, H. G. and Davis, R. A. (1993) Studies on aldose reductase inhibitors from fungi. 2. Moniliformin and small ring analogs. J. Enzyme Inhibition 7, 249-256.
56. Devamanoharan, P. S. and Varma, S. D. (1996) Studies on L-threose as substrate for aldose reductase-a possible role in preventing protein glycation. Mol. Cell. Biochem. 159, 123-127.
57. Dewinter, H. L. and Vonitzstein, M. (1995) Aldose reductase as a target for drug design - molecular modelling calculations on the binding of acyclic sugar substrates to the enzyme. Biochemistry 34, 8299-8308.
58. Donohue, P. J., Alberts, G. F., Hampton, B. S. and Winkles, J. A. (1994) A delayed-early gene activated by fibroblast growth factor-I encodes a protein related to aldose reductase. J. Biol. Chem. 269, 8604-8609.
59. Dorin, R. I., Shah, V. O., Kaplan, D. L., Vela, B. S. and Zager, P. G. (1995) Regulation of aldose reductase gene-expression in renal-cortex and medulla of rats. Diabetologia 38, 46-54.
60. Dugmore, W. N. and Tun, K. (1980) Glucose tolerance tests in 200 patients with senile cataract. Br. J. Ophthalmol. 64, 689-692.
61. Dupriest, M. T., Griffin, B. W., Kuzmich, D. and McNatt, L. G. (1991) Spiro [fluoreneisothiazolidin] one dioxides -new aldose reductase and L-hexonate dehydrogenase inhibitors. J. Med. Chem. 34, 3229-3234.
62. Dvornik, D., Hohman, T. C. and Basso, M. D. (1996) Aminoguanidine does not inhibit aldose reuctase activity in galactose-fed rats. J. Diabetes and its Complications 10, 23-30.
63. Edmands, S. and Yancey, P. H. (1992) Effects on rat renal osmolytes of extended treatment with an aldose reductase inhibitor. Comp. Biochem. Physiol. 103, 499-502.
64. Ehrig, T., Bohren, K. M., Prendergast, F. G. and Gabbay, K. H. (1994) Mechanism of aldose reductase inhibition -binding of NADP + /NADPH and alrestatin-like inhibitors. Biochemistry 33, 7157-7165.
65. Engerman, R. L. and Kern, T. S. (1987) Progression of incipient diabetic retinopathy during good glycaemic control. Diabetes 36, 808-812.
66. Engerman, R. L. and Kern, T. S. (1993) Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 42, 820-825.
67. Engerman, R. L., Kern, T. S. and Garment, M. B. (1993) Capillary basement-membrane in retina, kidney and muscle of diabetic dogs and galactosaemic dogs and its response to 5 years aldose reductase inhibition. J. Diabetes and its Complications 7, 241-245.
68. Engerman, R. L., Kern, T. S. and Larson, M. E. (1994) Nerve-conduction and aldose reductase inhibition during 5 years of diabetes or galactosemia in dogs. Diabetologia 37, 141-144.
69. Fabre, S., Manin, M., Pailhoux, E., Veyssiere, G. and Jean, C. (1994) Identification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein-specific to the mouse vas-deferens. J. Biol. Chem. 269, 5857-5864.
70. Faes, T. J. C., Yff, G. A., Deweerdt, O., Lanting, P., Heimans, J. J. and Bertelsmann, F. W. (1993) Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor. J. Neurol. 240, 156-160.
71. Feather, M. S., Flynn, T. G., Munro, K. A., Kubiseski, T. J. and Walton, D. J. (1995) Catalysis of reduction of carbohydrate 2-oxoaldehydes (osones) by mammalian aldose reductase and aldehyde reductase. Biochim. Biophys. Acta 1244, 10-16.
72. Feldman, H. B., Szozepanik, P. A. and Harne, P. et al. (1977) Stereospecificity of NADPH oxidation by AR2. Biochim. Biophys. Acta 480, 14-20.
73. Felicio, J. D., Goncalex, E., Braggio, M. M., Costantino, L., Albasini, A. and Lins, A. P. (1995) Inhibition of lens aldose reductase by biflavones from Ouratea spectabilis. Planta Medica 61, 217-220.
74. Ferraris, J. D., Williams, C. K., Jung, K. Y., Bedford, J. J., Burg, M. B. and Garciaperez, A. (1996) ORE, a eukaryotic minimal essential osmotic response element. J. Biol. Chem. 271, 18318-18321.
75. Ferraris, J. D., Williams, C. K., Martin, B. M., Burg, M. B. and Garciaperez, A. (1994) Cloning, genomic organization, and osmotic response of the aldose reductase gene. Proc. natn. Acad. Sci. USA 91, 10742-10746.
76. Fujita, T., Ohira, K., Miyatake, K., Nakano, Y. and Nakayama, M. (1995) Inhibitory effect of perilloside-A and perilloside-C, and related monoterpene glucosides on aldose reductase and their structure-activity relationships. Chem. Pharmaceut. Bull. 43, 920-926.
77. Furth, A. and Harding, J. J. (1989) Why sugar is bad for you. New Scientist 44-47.
78. + ATPase and its glucosylated derivative by AR2 inhibitor. Diabetes 36, 716-720.
79. Garner, M. H., Wang, G.-M. and Spector, A. (1987) Stimulation of glucosylated lens epithelial Na,K -ATPase by an AR2 inhibitor. Exp. Eye Res. 44, 339-354.
80. Glomb, M. A. and Monnier, V. M. (1995) Mechanism of protein modification by glyoxal and glycoaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270, 10017-10026.
81. Goldberg, B. and Stern, A. (1977) Autoxidation of ene-diols. Arch. Biochem. Biophys. 178, 218-225.
82. Gonzalez, R. G., Barnett, P. and Aguayo, J. et al. (1984) Direct measurement of polyol pathway activity in the ocular lens. Diabetes 33, 196-199.
83. Goode, D., Lewis, M. and Crabbe, M. J. C. (1995) Investigation of a putative xylitol pathway. Metabolism of inositol and glucuronate in the mammalian lens. Vision Res. 35, S194.
84. Goode, D., Lewis, M. E. and Crabbe, M. J. C. (1996) Accumulation of xylitol in the mammalian lens is related to glucuronate metabolism. FEBS Lett. 395, 174-178.
85. Goto, Y., Hotta, N., Shigeta, Y., Sakamoto, N. and Kikkawa, R. (1995) Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy - clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind-study. Biomed. Pharmacother. 49, 269-277.
86. Graham, A., Brown, L., Hedge, P. J., Gammack, A. J. and Markham, A. F. (1991a) Structure of the human aldose reductase gene. J. Biol. Chem. 266, 6872-6877.
87. Graham, A., Heath, P., Morten, J. E. N. and Markham, A. F. (1991b) The human aldose reductase gene maps to chromosome region-7Q35. Hum. Genet. 86, 509-514.
88. Greene, D. A. (1987) Neuropathy: disease of the peripheral nerves and lesions of the feet. In Diabetic Complications (M. J. C. Crabbe, ed.) pp. 66-93. Churchill Livingstone, Edinburgh.
89. Grimshaw, C. E., Bohren, K. M., Lai, C. J. and Gabbay, K. H. (1995a) Human aldose reductase-PK of tyrosine-48 reveals the preferred ionization state for catalysis and inhibition. Biochemistry 34, 14374-14384.
90. Grimshaw, C. E., Bohren, K. M., Lai, C. J. and Gabbay, K. H. (1995b) Human aldose reductase - subtle effects revealed by rapid kinetic-studies of the C298A mutant enzyme. Biochemistry 34, 14366-14373.
91. Grimshaw, C. E., Bohren, K. M., Lai, C. J. and Gabbay, K. H. (1995c) Human aldose reductase - rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. Biochemistry 34, 14356-14365.
92. Grimshaw, C. E. and Lai, C. J. (1996) Oxidised aldose reductase-in vivo factor, not in vitro artefact. Arch. Biochem. Biophys. 327, 89-97.
93. Grunewald, R. W., Weber, I. I., Kinnesaffran, E. and Kinne, R. K. H. (1993) Control of sorbitol metabolism in renal inner medulla of diabetic rats - regulation by substrate, cosubstrate and products of the aldose reductase reaction. Biochim. Biophys. Acta 1225, 39-47.
94. Halder, A. B. and Crabbe, M. J. C. (1984) Bovine lens aldehyde reductase (AR2). Biochem. J. 219, 33-39.
95. Halder, A. B. and Crabbe, M. J. C. (1985) Chemical modification studies on purified bovine lens aldose reductase. Ophthalmic Res. 17, 185-188.
96. Hamada, Y., Kito, R. and Raskin, P. (1991a) Increased erythrocyte aldose reductase activity in type-1 diabetic patients. Diabetic Med. 8, 226-231.
97. Hamada, Y., Kito, R. and Raskin, P. (1991b) Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes 40, 1233-1240.
98. Hamada, Y., Kito, R. and Raskin, P. (1993) Association of erythrocyte aldose reductase activity with diabetic complications in type-1 diabetes mellitus. Diabetic Med. 10, 33-38.
99. Hamada, Y., Odagaki, Y., Sakakibara, F., Naruse, K., Koh, N. and Hotta, N. (1995) Effects of an aldose reductase inhibitor on erythrocyte fructose 3-phosphate and sorbitol 3-phosphate levels in diabetic-patients. Life Sciences 57, 23-29.
100. Hara, T., Nakamura, J., Koh, N., Sakakibara, F., Hamada, Y., Sasaki, H., Naruse, K., Nakashima, E., Takeuchi, N., Inukai, S. and Hotta, N. (1995) An aldose reductase inhibitor TAT reduces ADP-induced platelet hyper-aggregation in streptozotocin-induced diabetic rats with neuopathy. J. Lab. Clin. Med. 126, 541-547.
101. Haraguchi, H., Ohmi, I. and Kubo, I. (1996a) Inhibition of aldose reductase by maesanin and related P-benzoquinone derivatives and effects on other enzymes. Bioorganic Med. Chem. 4, 49-53.
102. Haraguchi, H., Ohmi, I., Sakai, S., Fukuda, A., Toihara, Y., Fujimoto, T., Okamura, N. and Yagi, A. (1996b) Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes. J. Natural Products 59, 443-445.
103. Harding, J. J. (1991) Cataract. Chapman and Hall, London.
104. Harding, J. J. and Crabbe, M. J. C. (1984) The lens: development, proteins, metabolism and cataract. In: The Eye (H. Dawson, ed.) Vol. 1B, pp. 207-492. Academic Press, Orlando.
105. Harrison, D. H., Bohren, K. M., Ringe, D., Petsko, G. A. and Gabbay, K. H. (1994) Anion-binding site in human aldose reductase - mechanistic implications for the binding of citrate, cacodylate, and glucose-6-phosphate. Biochemistry 33, 2011-2020.
106. Harrison, D. H. T. (1995) All in the family. Nature Structural Biology 2, 719-720.
107. Harrison, D. H. T., Bohren, K. M. and Gabbay, K. H. (1996) Aldose reductase. Nature Structural Biology 3, 651.
108. Harrison, D. H. T., Boehren, K. M., Petsko, G. A., Ringe, D. and Gabbay, K. H. (1997) The Alsestatin double decker. Biochemistry 36, 16134-16140.
109. Hayase, F., Nagara, R. H. and Miyata, S. et al. (1989) Aging of proteins: immunological detection of a glucose-derived pyrrole. J. Biol. Chem. 263, 3758-3764.
110. Henry, D. N., Delmonte, M., Greene, D. A. and Killen, P. D. (1993) Altered aldose reductase gene-regulation in cultured human retinal-pigment epithelial-cells. J. Clin. Invest. 92, 617-623.
111. Hotta, N., Kakuta, H., Fukasawa, H., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Wakao, T., Hara, T., Mori, K., Naruse, K., Nakashima, E., Inukai, S. and Sakamoto, N. (1995a) Effect of a potent new aldose reductase inhibitor TAT on diabetic neuropathy in rats. Diabetes research and clinical practice 27, 107-117.
112. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Hara, T., Takeuchi, N., Inukai, S., Kasama, N., Fukasawa, H. and Kakuta, H. (1995b) An aldose reductase inhibitor TAT prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-diabetic rats. Eur. J. Clin. Invest. 25, 948-954.
113. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Wakao, T., Hara, T., Mori, K., Naruse, K., Nakashima, E. and Sakamoto, N. (1996) Effect of propionyl-L-carnitine on motor-nerve conduction, autonomic cardiac-function, and nerve blood-flow in rats with streptozotocin-induced diabetes - comparison with an aldose reductase inhibitor. J. Pharmacol. Exp. Ther. 276, 49-55.
114. Hunt, J. V., Dean, R. T. and Wolff, S. P. (1988) Hydroxyl radical production and autoxidative glycosylation. Biochem. J. 256, 205-212.
115. Hutton, J. C., Schofield, P. J. and Williams, J. F. et al. (1976) The effect of an unsaturated-fat diet on cataract formation in diabetic rats. Br. J. Nutr. 36, 161-177.
116. Inskeep, P. B., Ronfeld, R. A., Peterson, M. J. and Gerber, N. (1994) Pharmacokinetics of the aldose reductase inhibitor zopolrestat in humans. J. Clin. Pharmacol. 34, 760-766.
117. Ishii, A., Kotani, T., Nagaki, Y., Shibayama, Y., Toyomaki, Y., Okukado, N., Ienaga, K. and Okamoto, K. (1996) Highly selective aldose reductase inhibitors. 1. 3-(arylalkyl)-2,4,5-Trioxoimidazolidine-1-acetic acids. J. Med. Chem. 39, 1924-1927.
118. Ishii, H., Tada, H. and Isogai, S. (1998) An aldose reductase inhibitor prevents glucose-induced increase in TGF-β. Diabetologia 41, 362-364.
119. Isogai, S., Inokuchi, T. and Ohe, K. (1995) Effect of an aldose reductase inhibitor on glomerular-basement-membrane anionic sites in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Practice 30, 111-116.
120. Iwata, N., Hara, S., Nishimura, C., Takahashi, M., Mukai, T., Takayama, M. and Endo, T. (1996) Hormonalregulation of aldose reductase in rat ovary during the estrous-cycle. Eur J. Biochem. 235, 444-448.
121. Iwata, T., Minucci, S., McGowan, M. and Carper, D. (1997) Identification of a novel cis-element required for the constitutional activity and osmotoc response of the rat aldose reductase promoter. J. Biol. Chem. 212, 32500-32506.
122. Jagt, D. L. V., Kolb, N. S., Jagt, T. J. V., Chino, J., Martinez, F. J., Hunsaker, L. A. and Royer, R. E. (1995) Substrate-specificity of human aldose reductase - identification of 4-hydroxynonenal as an endogenous substrate. Biochim. Biophys. Acta 1249, 117-126.
123. James, D. E., Brown, R. and Navarro, J. et al. (1988) Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 333, 183-185.
124. Jaquinod, M., Potier, N., Klarskov, K., Reymann, J. M., Sorokine, O., Kieffer, S., Barth, P., Andriantomanga, V., Biellmann, J. F. and Vandorsselaer, A. (1993) Sequence of pig lens aldose reductase and electrospray mass-specttrometry of non-covalent and covalent complexes. Eur. J. Biochem. 218, 893-903.
125. Jedziniak, J. A., Chylack, L. T. and Cheng, H. M. et al. (1981) The sorbitol pathway in the human lens: AR2 and polyol dehydrogenase. Investigative Ophthalmology 20, 314-326.
126. Jez, J. M., Bennett, M. J., Schlegel, B. P., Lewis, M. and Penning, T. M. (1997) Anatomy of the aldo-keto reductase super family. Biochem. J. 326, 625-636.
127. Jiang, Z. Y., Zhou, Q. L., Eaton, J. W., Koppenol, W. H., Hunt, J. V. and Wolff, S. P. (1991) Spirohydantoin inhibitors of aldose reductase inhibit iron-catalyzed and copper-catalyzed ascorbate oxidation in vitro. Biochem. Pharmacol. 42, 1273-1278.
128. Kador, P. F., Kinoshita, J. H., Brittain, D. R., Mirrlees, D. J., Sennitt, C. M. and Stribling, D. (1986) Rat lens aldose reductase and polyol production. Biochem. J. 240, 233-237.
129. Kador, P. F., Lee, Y. S., Rodriguez, L., Sato, S., Bartoszkomalik, A., Abdelghany, Y. S. and Miller, D. D. (1995) Identification of an aldose reductase inhibitor site by affinity labeling. Bioorganic Med. Chem. 3, 1313-1324.
130. Kador, P. F., Robinson, W. G. and Kinoshita, J. H. (1985) The pharmacology of AR2 inhibitors. Ann. Rev. Pharmacol. Toxicol. 25, 691-714.
131. Kadota, S., Basnet, P., Hase, K. and Namba, T. (1994) Matteuorienate-A and matteuorienate-B, 2 new and potent aldose reductase inhibitors from Matteuccia orientals (hook) Trev.. Chem. Pharmaceut. Bull. 42, 1712-1714.
132. Kamijo, M., Cherian, P. V. and Sima, A. A. F. (1993) The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat. Diabetologia 36, 893-898.
133. Kato, N., Mizumo, K., Matsubara, A., Nakano, K., Kurono, M. and Yagihashi, S. (1994) Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-Fluoro-2′,5′-Dioxospiro-[chroman-4,4′-imidazolidine] -2-carboxamide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats. J. Diabetes and its Complications 8, 27-32.
134. Kawamura, T., Suzuki, K., Matsumae, H., Sano, T., Sakamoto, N. and Hotta, N. (1995) Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in-vitro. Diabetic Med. 12, 392-396.
135. Kern, T. S. and Engerman, R. L. (1991) Retinol polyol and myoinositol in galactosemic dogs given an aldose-reductase inhibitor. Invest. Ophthalmol. vis. Sci. 32, 3175-3177.
136. Khanna, P., Wang, L. F. and Ansari, N. H. (1996) Semiquantitation of messenger-RNA by polymerase chain-reaction-levels of oxidative defense enzymes and aldose reductase in rat lenses cultured in hyperglycemic or oxidative medium. Res. Commun. Mol. Pathol. Pharmacol. 92, 3-18.
137. Kicic, E. and Palmer, T. N. (1996) Increased white cell aldose reductase messenger RNA levels in diabetic patients. Diab. Res. Clin. Practice 33, 31-36.
138. Kinoshita, J. H. (1974) Mechanisms initiating cataract formation. Invest. Ophthalmol. 13, 713-724.
139. Kinoshita, J. H., Merola, L. O. and Dikmak, E. (1962) Osmotic changes in experimental galactose cataracts. Exp. Eye Res. 1, 405-410.
140. Klein, R., Klein, B. E. K. and Moss, S. E. (1984) Visual impairment in diabetes. Ophthalmology 91, 1-8.
141. Klein, R., Klein, B. E. K. and Moss, S. E. et al. (1985) Retinopathy in young-onset diabetic patients. Diabetes Care 8, 311-315.
142. Knott, R. M., Robertson, M. and Forrester, J. V. (1993) Regulation of glucose-transporter (glut-3) and aldose reductase messenger-RNA in bovine retinal endothelial-cells and retinal pericytes in high glucose and high galactose culture. Diabetologia 36, 808-812.
143. Ko, B. C. B., Lam, K. S. L., Wat, N. M. S. and Chung, S. S. M. (1995) An (A-C) (N) dinucleotide repeat polymorphic marker at the 5′-end of the aldose reductase gene is associated with early-onset diabetic-retinopathy in NIDDM patients. Diabetes 44, 727-732.
144. Ko, B. C. B., Ruepp, B., Bohren, K. M., Gabbey, K. H. and Chung, S. S. M. (1997) Identification and characterisation of multiple osmotic response elements. J. Biol. Chem. 272, 16431-16437.
145. Kohner, E. M. (1987) Microangiopathy: diabetic retinopathy. In: Diabetic Complications (M. J. C. Crabbe, ed.) pp. 41-65. Churchill Livingstone, Edinburgh.
146. Kolb, N. S., Hunsaker, L. A. and Vanderjagt, D. L. (1994) Aldose reductase-catalyzed reduction of acrolein - implications in cyclophosphamide toxicity. Mol. Pharmacol. 45, 797-801.
147. Kotecha, J. A., Feather, M. S., Kubiseski, T. J. and Walton, D. J. (1996) Catalysis of reduction of aldos-2-uloses (osones) by aldose reductase - selectivity for the aldehydic carbonyl group. Carbohydrate Res. 289, 77-89.
148. Kubiseski, T. J. and Flynn, T. G. (1995) Studies on human aldose reductase - probing the role of arginine-268 by site-directed mutagenesis. J. Biol. Chem. 270, 16911-16917.
149. Kubiseski, T. J., Green, N. C., Borhani, D. W. and Flynn, T. G. (1994) Studies on pig aldose reductase - identification of an essential arginine in the primary and tertiary structure of the enzyme. J. Biol. Chem. 269, 2183-2188.
150. Kubo, M., Matsuda, H., Tokuoka, K., Kobayashi, Y., Ma, S. P. and Tanaka, T. (1994) Studies of anticataract drugs from natural sources. 1. Effects of a methanolic extract and the alkaloidal components from corydalis tuber on in-vitro aldose reductase-activity. Biol. Pharmaceut. Bull. 17, 458-459.
151. Laeng, P., Bouillon, P., Taupenot, L. and Labourdette, G. (1995) Long-term induction of an aldose reductase protein by basic fibroblast growth factor in rat astrocytes in-vitro. Electrophoresis 16, 1240-1250.
152. Lau, E. T., Cao, D. L., Lin, C., Chung, S. K. and Chung, S. S. (1995) Tissue-specific expression of 2 aldose reductase-like genes in mice-abundant expression of mouse vas-deferens protein and fibroblast growth factor-regulated protein in the adrenal-gland. Biochem. J. 312, 609-615.
153. Lee, S. P. and Chen, T. H. H. (1993) Expression of an aldose reductase-related gene during the induction of freezing-tolerance in bromegrass cell-suspension cultures. J. Plant Physiol. 142, 749-753.
154. Lee, A. Y. W., Chung, S. K. and Chung, S. S. M. (1995) Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc. natn. Acad. Sci. USA 92, 2780-2784.
155. Lee, A. Y. W. and Chung, S. S. M. (1998) Involvement of aldose reductase in naphthalene cataract. Invest. Ophthal. Vis. Sci. 39, 193-197.
156. Leske, M. C. and Sperduto, R. D. (1983) The epidemiology of senile cataracts: a review. Am. J. Epidemiol. 118, 152-165.
157. Liu, S. Q., Bhatnagar, A., Ansari, N. H. and Srivastava, S. K. (1993a) Identification of the reactive cysteine residue in human placenta aldose reductase. Biochim. Biophys. Acta 1164, 268-272.
158. Liu, S. Q., Bhatnagar, A. and Srivastava, S. K. (1993b) Bovine lens aldose reductase - pH-dependence of steady-state kinetic-parameters and nucleotide-binding. J. Biol. Chem. 268, 25494-25499.
159. Lloyd, P. and Crabbe, M. J. C. (1985) High-performance liquid chromatographic analysis of glucose, fructose, sorbitol and low levels of the AR2 inhibitor sorbinil in human lens and plasma. J. Chromatogr. 343, 402-406.
160. Lou, M. F., Xu, G. T., Zigler, S. and York, B. (1996) Inhibition of naphthalene cataract in rats by aldose reductase inhibitors. Curr. Eye Res. 15, 423-432.
161. Lyons, P. A., Gould, S., Wise, P. H. and Palmer, T. N. (1991) Activation of erythrocyte aldose reductase in man in response to glycaemic challenge. Diabetes Res. Clin. Practice 14, 9-14.
162. Macchia, M., Menchini, E., Nencetti, S., Orlandini, E., Rossello, A. and Belfiore, M. S. (1996) Synthesis and aldose reductase inhibitory activity of some N-(Aroyl)-N-(Arylalkyloxy)-Glycines and N-(Aroyl)-N-(arylalkyloxy)-beta-alanines. Farmaco 51, 255-260.
163. Malamas, M. S. and Hohman, T. C. (1994) N-substituted spirosuccinimide, spiropyridazine, spiroazetidine and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. J. Med. Chem. 37, 2059-2070.
164. Malamas, M. S., Hohman, T. C. and Millen, J. (1994) Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3 diones-2-[(4-bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4(1h), 3′-pyrrolidine]-1,2′,3,5′ (2H)-tetrone and congeners. J. Med. Chem. 35, 2043-2058.
165. Marini, I., Bucchioni, L., Voltarelli, M., Delcorso, A. and Mura, U. (1995) Alpha-crystallin-like molecular chaperone against the thermal-denaturation of lens aldose reductase - the effect of divalent metal-ions. Biochem. and Biophysical Research Communications 212, 413-420.
166. Martial, S., Price, S. R. and Sands, J. M. (1995) Regulation of aldose reductase, sorbitol dehydrogenase, and taurine cotransporter messenger-RNA in rat medulla. J. Am. Soc. Nephrol. 5, 1971-1978.
167. Matsuda, H., Cai, H., Kubo, M., Tosa, H. and Iinuma, M. (1995) Study on anticataract drugs from natural sources. 2. Effects of Buddlejae flos on in-vitro aldose reductase-activity. Biol. and Pharmaceutical Bulletin 18, 463-466.
168. Matsumoto, K., Nagashima, K., Kamigauchi, T., Kawamura, Y., Yasuda, Y., Ishii, K., Uotani, N., Sato, T., Nakai, H., Terui, Y., Kikuchi, J., Ikenisi, Y., Yoshida, T., Kato, T. and Itazaki, H. (1995) Salfredins, new aldose reductase inhibitors produced by crucibulum SP RF-3817. 1. Fermentation, isolation and structures of salfredins. J. Antibiotics 48, 439-446.
169. Matsuura, K., Deyashiki, Y., Bunai, Y., Ohya, I. and Hara, A. (1996) Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal-glands. Arch. Biochem. Biophys. 328, 265-271.
170. Matsuura, K., Sato, K., Deyashiki, Y., Nakanishi, M. and Hara, A. (1995) 3-Deoxyglucosone reductase in dog adrenal glands - identification as aldose reductase. Biol. Pharmaceut. Bull. 18, 1765-1767.
171. McGowan, M. H., Iwata, T. and Carper, D. (1998) Characterisation of the mouse aldose reductase gene. Molecular Vision 4, 12-23.
172. Monge, L., Demattei, M., Dani, F., Sciarretta, A. and Carta, O. (1995) Effect of treatment with an aldose-reductase inhibitor on symptomatic carpal-tunnel syndrome in type-2 diabetes. Diabetic Med. 12, 1097-1101.
173. Muira, T. and Kato, A. (1996) Hypoglycemic and aldose reductase - activity of Polichia campestris. Biol. Pharmaceut. Bull. 19, 852-854.
174. Murata, M., Irie, J. and Homma, S. (1994) Aldose reductase inhibitors from green tea. Food Science and Technology-Lebensmittel-Wissenschaft and Technologie 27, 401-405.
175. Nagaraj, R. H., Prabhakaram, M., Ortwerth, B. J. and Monnier, V. M. (1994) Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase. Diabetes 43, 580-586.
176. Nakanishi, T., Yamauchi, A., Sugita, M. and Takamitsu, Y. (1996a) Aldose reductase and myoinositol transporter messenger-RNA are independently regulated in rat renal medulla. J. Am. Soc. Nephrol. 7, 283-289.
177. Nakanishi, T., Yamauchi, A., Yamamoto, S., Sugita, M. and Takamitsu, Y. (1996b) Potassium depletion modulates aldose reductase messenger RNA in rat renal inner medulla. Kidney Int. 50, 828-834.
178. Nakano, T. and Petrash, J. M. (1996) Kinetic and spectroscopic evidence for active-site inhibition of human aldose reductase. Biochemistry 35, 11196-11202.
179. Nakayama, K., Murakami, N., Ohta, M., Kato, K., Ida, K., Mizota, M., Miwa, I. and Okuda, J. (1995) Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats. Eur. J. Pharmacol. 276, 77-83.
180. Nicolucci, A., Carinci, F., Cavaliere, D., Scorpiglione, N., Belfiglio, M., Labbrozzi, D., Mari, D., Benedetti, M. M., Tohnoni, G. and Liberati, A. (1996) A meta-Janalysis of trials of aldose reductase inhibitors in Jdiabetic peripheral neuropathy. Diabetic Med. 13, 1017-1026.
181. Nishimura, C., Furue, M., Ito, T., Omori, Y. and Tanimoto, T. (1993) Quantiative determination of human aldose reductase by enzyme-linked immunosorbent assay of human aldose reductase. Biochem. Pharmacol. 46, 21-28.
182. Nishimura, C., Saito, T., Ito, T., Omori, Y. and Tanimoto, T. (1994) High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37, 328-330.
183. Ohta, M., Ii, S., Yamaoka, T., Ono, K., Kokai, Y., Fujimoto, J. I., Iwahana, H., Yoshimoto, K. and Itakura, M. (1995) Galactose-induced albuminuria in transgenic mice expressing human aldose reductase. Nutrition Research 15, 1343-1353.
184. Ohta, M., Tanimoto, T. and Hayakawa, T. (1994) Multiplicity of dog kidney high-K-M aldose reductase and conversion mechanism into aldose reductase. Int. J. Biochem. 26, 565-573.
185. Ohta, M., Tanimoto, T., Tanaka, A. and Hayakawa, T. (1993) Conversion of a NADPH-dependent aldehyde reducing enzyme into aldose reductase. Int. J. Biochem. 25, 1165-1174.
186. Okada, Y., Miyauchi, N., Suzuki, K., Kobayashi, T., Tsutsui, C., Mayuzumi, K., Nishibe, S. and Okuyama, T. (1995) Search for naturally-occurring substances to prevent the complications of diabetes. 2. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet-aggregation. Chem. Pharmaceut. Bull. 43, 1385-1387.
187. Okuda, Y., Kawashima, K., Suzuki, S., Asakura, Y., Asano, M., Tsurumaru, K., Dai, H. Q., Tachi, Y., Bannai, C., Saitoh, M. and Yamashita, K. (1996) Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. Life Sci. 60, PL53-PL56.
188. Ou, P., Nouroozzadeh, J., Tritschler, H. J. and Wolff, S. P. (1996) Activation of aldose reductase in rat lens and metal-ion chelation by ARIs and lipoic acid. Free Rad. Res. 25, 337-346.
189. Perkins, E. S. (1984) Cataract: refractive error, diabetes and morphology. Br. J. Opthalmol. 68, 293-297.
190. Petchey, M. and Crabbe, M. J. C. (1984) Analysis of carbohydrates in lens, erythrocytes, and plasma by high-performance liquid chromatography of nitrobenzoate derivatives. J. Chromatogr. 307, 180-184.
191. Phillips, S. A., Mirrlees, D. and Thornalley, P. J. (1993) Modification of the glyoxalase system in streptozotocin-induced diabetic rats - effect of the aldose reductase inhibitor statil. Biochem. Pharmacol. 46, 805-811.
192. Piatigorsky, J. and Wistow, G. J. (1989) Enzyme/crystallins: gene sharing as an evolutionary strategy. Cell 57, 197-199.
193. Plater, M. L., Goode, D. and Crabbe, M. J. C. (1996) Effects of site-directed mutations on the chaperone-like activity of alpha B crystallin. J. Biol. Chem. 271, 28558-28566.
194. Plater, M. L., Goode, D. and Crabbe, M. J. C. (1997) Ibuprofen protects alpha crystallin against post-translational modification by preventing protein cross linking. Ophthal. Res. 29, 421-428.
195. Pongor, S., Ulrich, P. C. and Bencsath, F. A. et al. (1984) Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. natn. Acad. Sci. USA 81, 2684-2688.
196. Ramirez, L. C., Arauz, C., Pruneda, L., Hammon, K., Rosenstock, J. and Raskin, P. (1991) The effect of aldose reductase inhibition with ponalrestat on the width of the capillary basement membrane in diabetes mellitus. Diabetes Res. Clin. Practice 11, 73-80.
197. Ratliff, D. M., Vanderjagt, D. J., Eaton, R. P. and Vanderjagt, D. L. (1996) Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and ploymorphonuclear cells from insulin-dependent diabetic-patients with diabetic complications - aldose reductase, glyoxalase-I, and glyoxalase-II - A clinical research-center study. J. Clin. Endocrinol. Metabolism 81, 488-492.
198. Reddi, A. S. and Jyothirmayi, G. N. (1993) Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long term diabetic rats. J. Diabetes and its Complications 7, 233-240.
199. Reddy, V. N., Schwass, D. and Chakrapani, B. et al. (1976) Biochemical changes associated with the development and reversal of galactose cataracts. Exp. Eye Res. 29, 299-332.
200. Richard, S., Tamas, C., Sell, D. R. and Monnier, V. M. (1991) Tissue-specific effects of aldose reductase inhibition on fluorescence and cross-linking of extracellular matrix in chronic galactosaemia-relationship to pentosidine cross-links. Diabetes 40, 1049-1056.
201. Rillaerts, E. G., Vertommen, J. J. and De Leeuw, I. H. (1988) Effect of statil (ICI 128436) on erythrocyte viscosity in vitro. Diabetes 37, 471-475.
202. Robey, C. and Dasmahapatra Am Cohen, M. P. et al. (1987) Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus. Diabetes 36, 1010-1013.
203. Robison, W. G., Laver, N. M., Jacot, J. L., Glover, J. P., Basso, M. D., Blouin, P. and Hohman, T. C. (1996) Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor way-121,509. Investigative Ophthalmology and Visual Science 37, 1149-1156.
204. Robison, W. G., Nagata, M. and Kinoshita, J. H. (1988) AR2 and retinal capillary basement membrane thickening. Exp. Eye Res. 46, 343-348.
205. Roll, B., Vanboekel, M. A. M., Amons, R. and Dejong, W. W. (1995) ρ-B-Crystallin, an aldose reductase-like lens protein in the gecko Lepidodactylis lugubris. Biochem. Biophys. Res. Commun. 217, 452-458.
206. Roncarati, R., Salamini, F. and Bartels, D. (1995) An aldose reductase homologous gene from barley-regulation and function. Plant J. 7, 809-822.
207. Ruepp, B., Bohren, K. M. and Gabbay, K. H. (1996) Characterisation of the osmotic response element of the human aldose reductase gene promoter. Proc. natn. Acad. Sci. USA 93, 8624-8629.
208. Sands, J. M. and Schrader, D. C. (1991) Acute changes in intracellular ions or pH and regulation of aldose reductase activity. J. Am. Soc. Nephrology 2, 212-218.
209. Sastry, S. G., Sanders, R. A., Veltman, J. C. and Watkins, J. B. (1995) Minimal effects of 2 aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits. Drug Metabolism Disposition 23, 1094-1098.
210. Sato, S. (1993) Aldose reductase: the major protein associated with naphthalene dihydrodiol dehydrogenase-activity in rat lens. Invest. Ophthalmol. vis. Sci. 34, 3172-3178.
211. Sato, K., Inazu, A., Yamaguchi, S., Nakayama, T., Deyashiki, Y., Sawada, H. and Hara, A. (1993) Monkey 3-seoxyglucasone reductase - tissue distribution and purification of 3 multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase and aldose reductase. Arch. Biochem. Biophys. 307, 286-294.
212. Schouten, J. A. (1993) Aldose reductase inhibition with sorbinil in symptomatic diabetic neuropathy - a 3 month clinical and neurophysiological study. Clinical Trials and Meta-Analysis 28, 203-214.
213. Sekiguchi, M., Watanabe, K., Eto, M., Iwashima, Y., Morikawa, A., Takahashi, M., Ishii, K. and Makino, I. (1991) Polyol pathway in tissues of spontaneously diabetic Chinese-hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235. Comp. Biochem. Physiol. B 98, 637-640.
214. Severi, F., Costantino, L., Benvenuti, S., Vampa, G. and Mucci, A. (1996) Synthesis and description of chalcone-like compounds, inhibitors of aldose reductase. Med. Chem. Res. 6, 128-136.
215. Sharma, Y. R. and Cotlier, E. (1982) Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac. Exp. Eye Res. 35, 21-27.
216. Shaw, S. and Crabbe, M. J. C. (1994a) Minimising spurious receptor-binding kinetics with modified proteins. Analyt. Biochem. 219, 161-163.
217. Shaw, S. and Crabbe, M. J. C. (1994b) Non-specific binding of advanced glycosylation endproducts (AGEs) to macrophages outweighs specific receptor-mediated interactions. Biochem. J. 304, 121-129.
218. Shaw, S. M. and Crabbe, M. J. C. (1994c) Monitoring the progress of non-enzymatic glycation in vitro. Int. J. Peptide and Protein Res. 44, 594-602.
219. Shaw, S. M. and Crabbe, M. J. C. (1995) Non-specific binding of lysine-glucose-derived Maillard products to macrophages outweighs specific receptor-mediated interactions. Food Chem. 52, 399-404.
220. Shi, S. and Bekhor, I. (1994) Abnormal expression of aldose reductase messenger-RNA in fiber cells of cataractous rat lens - analysis by in-situ hybridization. Mol. Cell. Biochem. 131, 35-41.
221. Shin, K. H., Kang, S. S., Seo, E. A. and Shin, S. W. (1995) Isolation of aldose reductase inhibitors from the flowers of Chrysanthemum boreale. Arch. Pharm. Res. 18, 65-68.
222. Shmohara, M., Thornally, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J. and Brounlee, M. (1998) Overexpression of glyozalane I in bovine endothelial cells inhibits its intracellular AGE formation. J. Clin. Invest. 101, 1142-1147.
223. Singh, B. M. and Nattrass, M. (1987) The clinical care of diabetics: prevention, diagnosis and treatment of complications. In: Diabetic Complications (M. J. C. Crabbe, ed.) pp. 221-252. Churchill Livingstone, Edinburgh.
224. Sommer, A. (1981) Diabetes and senile cataract. Am. J. Ophthalmol. 92, 134-135.
225. Soulisliparota, T., Cooper, M. E., Dunlop, M. and Jerums, G. (1995) The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 38, 387-394.
226. Sousa, R. L. and Marlatta, M. A. (1985) Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin. Arch. Biochem. Biophys. 240, 345-357.
227. Spycher, S., Tabatabavakill, S., O'Donnell, V. B., Palomba, L. and Azzi, A. (1996) 4-Hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem. Biophys. Res. Commun. 226, 512-516.
228. Srivastava, S. K., Ansari, N. H. and Hair, G. A. et al. (1984) Aldose and aldehyde reductase in human tissues. Biochim. Biophys. Acta 800, 220-227.
229. Srivastava, S., Chandra, A., Bhatnagar, A., Srivastava, S. K. and Ansari, N. H. (1995) Lipid-peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Commun. 217, 741-746.
230. Stevens, E. J., Willars, G. B., Lidbury, P., House, F. and Tomlinson, D. R. (1993a) Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats - effects of insulin or aldose reductase inhibition. Br. J. Pharmacol. 109, 980-986.
231. +)-ATPase in the slowing of nerve-conduction in the streptozotocin-diabetic rat. J. Clin. Invest. 94, 853-859.
232. Stevens, M. J., Henry, D. N., Thomas, T. P., Killen, P. D. and Greene, D. A. (1993b) Aldose reductase gene-expression and osmotic dysregulation in cultured human retinal-pigment epithelial-cells. Am. J. Physiol. 265, E428-E438.
233. Stracke, H. and Dietrich, E. (1994) Influence of ponalrestat, an aldose-reductase inhibitor, on diabetic polyneuropathy. Medizinische Welt 45, 84-89.
234. Stribling, D. and Perkins, M. (1987) AR2 inhibitors. In: Recent Advances in Diabetes (M. Nattrass, ed.) Vol. 2, pp. 169-176. Churchill Livingstone, Edinburgh.
235. Suarez, G., Rajaram, R., Oronsky, A. L. and Gawinowicz, M. A. (1989) Nonenzymic glycation of bovine serum by fructose (fructation). J. Biol. Chem. 264, 3674-3679.
236. Sugai, J. K. and Delgenes, J. P. (1995a) Catabolite repression of induction of aldose reductase - activity and utilization of mixed hemicellulosic sugars in Candida guilliermondii. Curr. Microbiol. 31, 239-244.
237. Sugai, J. K. and Delgenes, J. P. (1995b) Induction of aldose reductase-activity in Candida guilliermondii by pentose sugars. J. Indust. Microbiol. 14, 46-51.
238. Swergold, B. S., Kappler, F. and Brown, T. R. (1990) Identification of fructose 3-phosphate in the lens of diabetic rats. Science 241, 451-454.
239. Takahashi, M., Fujii, J., Miyoshi, E., Hoshi, A. and Taniguchi, N. (1995) Elevation of aldose reductase gene-expression in rat primary hepatoma and hepatoma-cell lines - implication in detoxification of cytotoxic aldehydes. Int. J. Cancer 62, 749-754.
240. Takahashi, M., Hoshi, A., Fujii, J., Miyoshi, E., Kasahara, T., Suzuki, K., Aozasa, K. and Taniguchi, N. (1996) Induction of aldose reductase gene-expression in lec rats during the development of the hereditary hepatitis and hepatoma. Jap. J. Cancer Res. 87, 337-341.
241. Tanimoto, T., Fukuda, H. and Kawamura, J. (1984) Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens. Yakugaku Zasshi 104, 631-634.
242. Tao, R. V., Takahashi, Y. and Kador, P. F. (1991) Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat. Invest. Ophthalmol. vis. Sci. 32, 1630-1637.
243. Tarle, I., Borhani, D. W., Wilson, D. K., Quiocho, F. A. and Petrash, J. M. (1993) Probing the active-site of human aldose reductase-site-directed mutagenesis of ASP-43, TYR-48, LYS-77, and HIS-110. J. Biol. Chem. 268, 25687-25693.
244. +-K+ pump activity in diabetic rabbit carotid-artery-reversal by aldose reductase inhibition. Am. J. Physiol. 265, H1189-H1194.
245. Tetefavier, F., Barth, P., Mitchler, A., Podjarny, A. D., Rondeau, J. M., Urzhumtsev, A., Biellmann, J. F. and Moras, D. (1995) Aldose reductase from pig lens. Eur. J. Med. Chem. 30, S589-S603.
246. Thornalley, P. J., Wolff, S. P. and Crabbe, M. J. C. et al. (1984a) The oxidation of oxyhaemoglobin by glyceraldehyde and other simple monosaccharides. Biochem. J. 217, 615-622.
247. Thornalley, P. J., Wolff, S. P. and Crabbe, M. J. C. et al. (1984b) The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochim. Biophys. Acta 797, 276-287.
248. Toyomizu, M., Sugiyama, S., Jin, R. L. and Nakatsu, T. (1993) Alpha-glucosidase and aldose reductase inhibitors - constituents of cashew, Anacardium occidentale, nut shell liquids. Phytother. Res. 7, 252-254.
249. Tsai, S. C. and Burnakis, T. G. (1993) Aldose reductase inhibitors - an update. Ann. Pharmacother. 27, 751-754.
250. Tsubota, K., Yoshida, M., Toda, T., Ono, M., Kajiwara, K. and Cheng, H. M. (1993) Aldose reductase inhibition and the P-31 profile of the intact diabetic rat lens. Ophthalmic Res. 25, 393-399.
251. Uchida, K., Kigoshi, T., Nakano, S., Ishii, T., Kitazawa, M. and Morimoto, S. (1995) Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes-mellitus. Clin. Therapeutics 17, 460-466.
252. Van der Jagt, D. L., Robinson, B., Taylor, K. K. and Hunsacker, L. A. (1992) J. Biol. Chem. 267, 4364-4369.
253. Vangerven, J. M. A., Boot, J. P., Lemkes, H. H. P. J. and Vanbest, J. A. (1994) Effects of aldose reductase inhibition with tolrestat on diabetic-retinopathy in a 6 months double-blind trial. Doc. Ophthalmol. 87, 355-365.
254. Vangerven, J. M. A. and Tjonatsien, A. M. L. (1995) The efficacy of aldose reductase inhibitors in the management of diabetic complications - comparison with intensive insulin-treatment and pancreatic transplantation. Drugs and Aging 6, 9-28.
255. Van Heyningen, R. (1959) Formation of ployols by the lens of the rat with sugar cataract. Nature 184, 194-195.
256. Van Heyningen, R. and Harding, J. J. (1986) Do aspirin-like analgesics protect against cataract? Lancet I, 1111-1113.
257. Vartanov, S. S., Pavlov, A. R. and Yaropolov, A. I. (1990) Regulation of the aldose reductase-activity of the eye lens - nonhyperbolic kinetics of the oxidation of NADPH by glucose. Biochemistry-Russia 55, 1526-1535.
258. Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., Bucala, R., Cerami, A., Egan, J. and Ulrich, P. (1996) An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382, 275-278.
259. Vlassara, H., Bucala, R. and Striker, L. (1994) Pathogenic effects of advanced glycosylation. Lab. Invest. 70, 138-151.
260. Wang, K., Bohren, K. M. and Gabbay, K. H. (1993) Characterization of the human aldose reductase gene promoter. J. Biol. Chem. 268, 16052-16058.
261. Warren, J. C., Murdock, G. L., Ma, Y., Goodman, S. R. and Zimmer, W. E. (1993) Molecular cloning of testicular 20-alpha-hydroxysteroid dehydrogenase - identity with aldose reductase. Biochemistry 32, 1401-1406.
262. Wegener, A., Fichtner, J. and Moltrecht, R. et al. (1986) Prevention of maphthalene cataract by an AR2 inhibitor. Proc. Int. Soc. Eye Res. 4, 80.
263. Wen, Y. and Bekhor, I. (1993) Levels of expression of hexokinase, aldose reductase and sorbitol dehydrogenase genes in lens of mouse and rat. Curr. Eye Res. 12, 323-332.
264. Wermuth, B. (1985) Aldo-keto reductases. Enzymology of Carbonyl Metabolism 2, 209-230.
265. Willars, G. B., Lambourne, J. E. and Tomlinson, D. R. (1987) Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes. Diabetes 36, 1425-1431.
266. Williams, W. F. and Odom, J. D. (1987) The utilisation of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses. Exp. Eye Res. 44, 717-730.
267. Williamson, J. R., Chang, K. and Tilton, R. G. et al. (1987) Increased vascular permeability in spontaneous diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes. Diabetes 36, 813-821.
268. Wilson, D. K. et al. (1992) Structure of human aldose reductase. Science 257, 81-84.
269. Wilson, D. K., Tarle, I., Petrash, J. M. and Quiocho, F. A. (1993) Refined 1.8-angstrom structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc. natn. Acad. Sci. USA 90, 9847-9851.
270. Wirth, H.-P. and Wermuth, B. (1985) Immunochemical characterisation of aldo-keto reductases. FEBS Lett. 187, 280-286.
271. Wolff, S. P. (1987) The potential role of oxidative stress in diabetes and its complications: novel implications for theory and therapy. In: Diabetic Complications (M. J. C. Crabbe, ed.) pp. 167-220. Churchill Livingstone, Edinburgh.
272. Wolff, S. P. and Crabbe, M. J. C. (1985) Low apparent AR2 activity produced by monosaccharide autoxidation. Biochem. J. 226, 625-630.
273. Wolff, S. P., Crabbe, M. J. C. and Thornalley, P. J. (1984) The autoxidation of glyceraldehyde and other simple monosaccharides. Experientia 40, 244-246.
274. Wu, R. R., Lyons, P. A., Wang, A., Sainbury, A. J., Chung, S. and Palmer, T. N. (1993) Effects of galactose feeding on aldose reductase gene-expression. J. Clin. Invest. 92, 155-159.
275. Wutrich, A. and Schatzmann, H. J. (1980) Inhibition of the red cell calcium pump by quercetin. Cell Calcium 1, 21-35.
276. Yagihashi, S., Yamagishi, S. I., Wada, R., Sugimoto, K., Baba, M., Wong, H. G., Fujimoto, J., Nishimura, C. and Kokai, Y. (1996) Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetes 45, 56-59.
277. Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J. and Kokai, Y. (1995) Acute onset of diabetic pathological-changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38, 255-261.
278. +-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats. Diabetes 36, 1414-1419.
279. Zeindleberhart, E., Jungblut, P. R., Otto, A. and Rabes, H. M. (1994) Identification of tumor-associated protein variants during rat hepatocarcinogenesis-aldose reductase. J. Biol. Chem. 269, 14589-14594.
280. Ziegler, D., Mayer, P., Rathmann, W. and Gries, F. A. (1991) One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy. Diabetes Research and Clinical Practice 14, 63-74.
281. Zoubi, S. A., Williams, M. D., Mayhew, T. M. and Sparrow, R. A. (1995) Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine - a quantitative study on the effects of insulin and aldose reductase inhibition. Virchows Archive 427, 187-193.